BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32849498)

  • 21. Zn(II)-curcumin solid dispersion impairs hepatocellular carcinoma growth and enhances chemotherapy by modulating gut microbiota-mediated zinc homeostasis.
    Wu R; Mei X; Ye Y; Xue T; Wang J; Sun W; Lin C; Xue R; Zhang J; Xu D
    Pharmacol Res; 2019 Dec; 150():104454. PubMed ID: 31526871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota.
    Dong M; Meng Z; Kuerban K; Qi F; Liu J; Wei Y; Wang Q; Jiang S; Feng M; Ye L
    Cell Death Dis; 2018 Oct; 9(10):1039. PubMed ID: 30305604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-17A-producing gammadeltaT cells promote CTL responses against Listeria monocytogenes infection by enhancing dendritic cell cross-presentation.
    Xu S; Han Y; Xu X; Bao Y; Zhang M; Cao X
    J Immunol; 2010 Nov; 185(10):5879-87. PubMed ID: 20956351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invariant natural killer T cell deficiency leads to the development of spontaneous liver inflammation dependent on γδT cells in mice.
    Nishio K; Miyagi T; Tatsumi T; Mukai K; Yokoyama Y; Yoshioka T; Sakamori R; Hikita H; Kodama T; Shimizu S; Shigekawa M; Nawa T; Yoshihara H; Hiramatsu N; Yamanaka H; Seino K; Takehara T
    J Gastroenterol; 2015 Nov; 50(11):1124-33. PubMed ID: 25791517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing effect of tumor necrosis factor (TNF)-alpha, but not IFN-gamma, on the tumor-specific cytotoxicity of gammadeltaT cells from glioblastoma patients.
    Suzuki Y; Fujimiya Y; Ohno T; Katakura R; Yoshimoto T
    Cancer Lett; 1999 Jun; 140(1-2):161-7. PubMed ID: 10403555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMGN2: An Antitumor Effector Molecule of γδT Cells.
    Chen J; Fan Y; Cui B; Li X; Yu Y; Du Y; Chen Q; Feng Y; Zhang P
    J Immunother; 2018 Apr; 41(3):118-124. PubMed ID: 29401165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.
    Li X; Zhang Z; Lin G; Gao Y; Yan Z; Yin H; Sun B; Wang F; Zhang H; Chen H; Cao D
    Tumour Biol; 2016 Aug; 37(8):11267-78. PubMed ID: 26951511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanistic study of nimesulide on enhancing gammadeltaT cell-mediated killing of gastric cancer cells].
    Liu JQ; Chen FX; Gong XJ; Li HZ; Cai K; Zhang BF; Zhang S; Zhang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Mar; 26(3):261-3, 266. PubMed ID: 20230693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut Microbiota Regulates Mincle Mediated Activation of Lung Dendritic Cells to Protect Against
    Negi S; Pahari S; Bashir H; Agrewala JN
    Front Immunol; 2019; 10():1142. PubMed ID: 31231363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells.
    Alrafas HR; Busbee PB; Nagarkatti M; Nagarkatti PS
    J Leukoc Biol; 2019 Aug; 106(2):467-480. PubMed ID: 30897248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer.
    Yuan L; Zhang S; Li H; Yang F; Mushtaq N; Ullah S; Shi Y; An C; Xu J
    Biomed Pharmacother; 2018 Dec; 108():184-193. PubMed ID: 30219675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma.
    Gao H; Li K; Tu H; Pan X; Jiang H; Shi B; Kong J; Wang H; Yang S; Gu J; Li Z
    Clin Cancer Res; 2014 Dec; 20(24):6418-28. PubMed ID: 25320357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
    Seo N; Tokura Y; Takigawa M; Egawa K
    J Immunol; 1999 Jul; 163(1):242-9. PubMed ID: 10384122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early-Life Antibiotic-Driven Dysbiosis Leads to Dysregulated Vaccine Immune Responses in Mice.
    Lynn MA; Tumes DJ; Choo JM; Sribnaia A; Blake SJ; Leong LEX; Young GP; Marshall HS; Wesselingh SL; Rogers GB; Lynn DJ
    Cell Host Microbe; 2018 May; 23(5):653-660.e5. PubMed ID: 29746836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycyrrhiza polysaccharides may have an antitumor effect in γδT cells through gut microbiota and TLRs/NF-κB pathway in mice.
    Chen Y; Li Z; Bai L; Lu B; Peng Y; Xu P; Song X; Bian Y; Wang X; Zhao S
    FEBS Open Bio; 2024 Jun; 14(6):1011-1027. PubMed ID: 38604998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut Dysbiosis Thwarts the Efficacy of Vaccine Against
    Nadeem S; Maurya SK; Das DK; Khan N; Agrewala JN
    Front Immunol; 2020; 11():726. PubMed ID: 32508806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice.
    Aguilera M; Cerdà-Cuéllar M; Martínez V
    Gut Microbes; 2015; 6(1):10-23. PubMed ID: 25531553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response.
    Delaune V; Orci LA; Lacotte S; Peloso A; Schrenzel J; Lazarevic V; Toso C
    Expert Opin Biol Ther; 2018 Oct; 18(10):1061-1071. PubMed ID: 30173562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.
    Ekmekciu I; von Klitzing E; Fiebiger U; Neumann C; Bacher P; Scheffold A; Bereswill S; Heimesaat MM
    Front Cell Infect Microbiol; 2017; 7():167. PubMed ID: 28529928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.